Literature DB >> 23057776

The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN.

Satoko Kojima1, Kei Kawana, Kensuke Tomio, Aki Yamashita, Ayumi Taguchi, Shiho Miura, Katsuyuki Adachi, Takeshi Nagamatsu, Kazunori Nagasaka, Yoko Matsumoto, Takahide Arimoto, Katsutoshi Oda, Osamu Wada-Hiraike, Tetsu Yano, Yuji Taketani, Tomoyuki Fujii, Danny J Schust, Shiro Kozuma.   

Abstract

PROBLEM: Local adaptive cervical regulatory T cells (Tregs) are the most likely direct suppressors of the immune eradication of cervical intraepithelial lesion (CIN). PD-1 expression on T cells induces Tregs. No studies have quantitatively analyzed the Tregs and PD-1+ cells residing in CIN lesions. METHOD OF STUDY: Cervical lymphocytes were collected using cytobrushes from CIN patients and analyzed by FACS analysis. Comparisons were made between populations of cervical Tregs and PD-1+ CD4+ T cells in CIN regressors and non-regressors.
RESULTS: A median of 11% of cervical CD4+ T cells were Tregs, while a median of 30% were PD-1+ cells. The proportions of cervical CD4+ T cells that were Tregs and/or PD-1+ cells were significantly lower in CIN regressors when compared with non-regressors.
CONCLUSIONS: The prevalence of cervical tolerogenic T cells correlates inversely with spontaneous regression of CIN. Cervical Tregs may play an important role in HPV-related neoplastic immunoevasion.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 23057776     DOI: 10.1111/aji.12030

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  13 in total

Review 1.  Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerations.

Authors:  Teresa C Longoria; Krishnansu S Tewari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

2.  Moving forward with human papillomavirus immunotherapies.

Authors:  Nicolas Çuburu; John T Schiller
Journal:  Hum Vaccin Immunother       Date:  2016-07-07       Impact factor: 3.452

3.  Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia.

Authors:  Linda Hertlein; Thomas Kolben; Aurelia Vattai; Nadine Kremer; Sarah Meister; Susanne Beyer; Lucia Keilmann; Anna Hester; Mina Temelkov; Helene Heidegger; Elisa Schmoeckel; Mirjana Kessler; Sven Mahner; Udo Jeschke
Journal:  J Cancer Res Clin Oncol       Date:  2021-11-05       Impact factor: 4.553

4.  Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.

Authors:  Wen Yang; Yan Song; Yun-Long Lu; Jun-Zhong Sun; Hong-Wei Wang
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

5.  Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis.

Authors:  Kathryn M Frietze; Rebeccah Lijek; Bryce Chackerian
Journal:  Expert Rev Vaccines       Date:  2018-10-20       Impact factor: 5.217

Review 6.  Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions.

Authors:  Z K Tuong; K Noske; P Kuo; A A Bashaw; S M Teoh; I H Frazer
Journal:  Papillomavirus Res       Date:  2017-10-19

7.  Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization.

Authors:  Hyeyoon Chang; Jin Hwa Hong; Jae Kwan Lee; Hyun Woong Cho; Yung Taek Ouh; Kyung Jin Min; Kyeong A So
Journal:  J Gynecol Oncol       Date:  2018-01-29       Impact factor: 4.401

8.  T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.

Authors:  Andrew W Woodham; Lisa Yan; Joseph G Skeate; Daniel van der Veen; Heike H Brand; Michael K Wong; Diane M Da Silva; W Martin Kast
Journal:  Papillomavirus Res       Date:  2016-12

9.  T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.

Authors:  Krystle A Lang Kuhs; Shih-Wen Lin; Xing Hua; Mark Schiffman; Robert D Burk; Ana Cecilia Rodriguez; Rolando Herrero; Christian C Abnet; Neal D Freedman; Ligia A Pinto; David Hamm; Harlan Robins; Allan Hildesheim; Jianxin Shi; Mahboobeh Safaeian
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

10.  Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia.

Authors:  Satoshi Baba; Ayumi Taguchi; Akira Kawata; Konan Hara; Satoko Eguchi; Mayuyo Mori; Katsuyuki Adachi; Seiichiro Mori; Takashi Iwata; Akira Mitsuhashi; Daichi Maeda; Atsushi Komatsu; Takeshi Nagamatsu; Katsutoshi Oda; Iwao Kukimoto; Yutaka Osuga; Tomoyuki Fujii; Kei Kawana
Journal:  Virol J       Date:  2020-03-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.